News
The most recent news and industry headlines are presented in this section. Our dedicated team closely observes the pharmaceutical industry and keeps you informed of the most recent developments around the Europe.
Celanese and Secarna Pharmaceuticals Collaborate on RNA Research for Prolonged Antisense Therapies
Thursday, March 21, 2024Celanese Corporation a global specialty materials and chemical company and Secarna Pharmaceuticals GmbH Co KG an independent European antisense drug discovery and development
FDA Fast Tracks Phanes Therapeutics' PT886 for Metastatic Claudin 18.2-Positive Pancreatic Adenocarcinoma Treatment
Thursday, March 21, 2024Phanes Therapeutics Inc a leading biotechnology company specializing in innovative oncology drug discovery and development made an announcement today regarding PT The US Food and Drug
Tetra Pharm Technologies Introduces Innovative Pain Relief Drug in the United Kingdom
Wednesday, March 20, 2024Following its successful launch in Germany last year the cannabinoidbased product XATEPA is set to be introduced to patients in the United Kingdom during the second quarter of
Vicore Receives FDA Breakthrough Device Designation for AlmeeTM: A Digital Therapy Aimed at Treating Patients with Pulmonary Fibrosis
Wednesday, March 20, 2024Vicore Pharma Holding AB has achieved a significant milestone in medical innovation with its breakthrough therapy AlmeeTM This digital cognitive behavioral therapy designed to address anxiety
Forge Biologics' FBX-101, an Innovative AAV Gene Therapy for Krabbe Disease, Granted Innovation Passport Designation in the UK
Wednesday, March 20, 2024Forge Biologics a subsidiary of Ajinomoto BioPharma Services focused on genetic medicine has announced a significant achievement today The Medicines and Healthcare Products Regulatory Agency
Eureka Therapeutics Advances ARYA-3 Clinical Trial to Phase II for Liver Cancer Treatment Utilizing GPC3-Targeting ARTEMIS® T-cell Therapy
Tuesday, March 19, 2024Eureka Therapeutics Inc a leading biotechnology company specializing in Tcell therapies for cancer has announced a significant milestone with its ARYA clinical trial advancing to Phase II
Selvita Introduces Biologic Drug Discovery and Development Services
Monday, March 18, 2024Selvita SA has announced a strategic initiative to expand its service portfolio significantly marking its entry into the field of biologic drug discovery and development This expansion includes the addition of comprehensive capabilities
Biotheus and Hansoh Pharma Expand Collaboration for EGFR/cMET Bispecific Antibody-Drug Conjugate Development
Saturday, March 16, 2024Biotheus Inc and Hansoh Pharmaceutical Group Co Ltd have announced an extension of their strategic collaboration building upon their existing partnership since In this expanded agreement
Charles River and Navega Therapeutics Announce Comprehensive Collaboration for Gene Therapy Manufacturing
Friday, March 15, 2024Charles River Laboratories International Inc and Navega Therapeutics Inc a biotech company specializing in epigenetic gene therapies have recently unveiled a collaborative agreement for an AAV
Antheia and Olon Extend Partnership for Biomanufacturing Essential Raw Materials and Active Pharmaceutical Ingredients
Thursday, March 14, 2024Antheia a company focused on revolutionizing essential medicines supply chains through innovative pharmaceutical ingredients has announced a partnership with Olon Group a prominent player
